Medicine

Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma

H. Cardenes, T. Price, S. Perkins, M. Maluccio, P. Kwo, T. Breen, M. Henderson, T. Schefter, K. Tudor, Jill Deluca, P. Johnstone

2010.3.27Clinical & Translational Oncology

DOI: 10.1007/s12094-010-0492-x

tlooto Summary

SBRT is a non-invasive feasible and well tolerated therapy in adequately selected patients with HCC and the preliminary local control and survival are encouraging.

Abstract

Abstract is not available.

Citation format

CARDENES, H., et al. Phase i feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma. Clinical & Translational Oncology, 2010, 12: 218–225.